{"id":31731,"date":"2025-03-10T10:59:47","date_gmt":"2025-03-10T09:59:47","guid":{"rendered":"https:\/\/ggba.swiss\/limula-unveils-limone-a-breakthrough-in-automated-cell-therapy-manufacturing\/"},"modified":"2025-03-10T11:01:46","modified_gmt":"2025-03-10T10:01:46","slug":"limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/","title":{"rendered":"Limula d\u00e9voile sa plateforme de fabrication de th\u00e9rapie cellulaire automatis\u00e9e LimONE"},"content":{"rendered":"\n<p>L\u2019entreprise vaudoise <a href=\"https:\/\/limula.ch\/\">Limula<\/a> a fait un grand pas en avant dans le domaine de la th\u00e9rapie cellulaire et g\u00e9nique (TCG) en d\u00e9voilant LimONE, une solution de fabrication de bout en bout con\u00e7ue pour relever les d\u00e9fis du co\u00fbt, de l&rsquo;\u00e9volutivit\u00e9 et de la standardisation des processus dans la production de th\u00e9rapies cellulaires personnalis\u00e9es. Pr\u00e9sent\u00e9e par Luc Henry, CEO de Limula, lors de l&rsquo;Advanced Therapies Week \u00e0 Dallas, la plateforme est destin\u00e9e \u00e0 transformer la mani\u00e8re dont les h\u00f4pitaux, les entreprises de biotechnologie et les organisations de d\u00e9veloppement et de fabrication sous contrat (CDMO) g\u00e8rent la production de th\u00e9rapies cellulaires.<\/p>\n\n\n\n<p>LimONE regroupe plusieurs op\u00e9rations unitaires en un seul consommable ferm\u00e9, ce qui minimise les \u00e9tapes \u00e0 forte intensit\u00e9 de main-d&rsquo;\u0153uvre, r\u00e9duit les besoins en infrastructure et garantit la coh\u00e9rence des processus. Cette innovation permet la production de plusieurs types de th\u00e9rapies cellulaires, notamment les cellules CAR-T et les cellules souches h\u00e9matopo\u00ef\u00e9tiques g\u00e9n\u00e9tiquement modifi\u00e9es. En utilisant le m\u00eame consommable tout au long des phases de d\u00e9veloppement, Limula \u00e9limine les transferts de technologie co\u00fbteux et chronophages, qui retardent souvent les essais cliniques.<\/p>\n\n\n\n<p>L&rsquo;approche de l&rsquo;entreprise combine l&rsquo;ing\u00e9nierie de pr\u00e9cision suisse et une expertise approfondie en mati\u00e8re de technologie cellulaire g\u00e9n\u00e9tiquement modifi\u00e9e. En partenariat avec la soci\u00e9t\u00e9 de design industriel Fjaryl, bas\u00e9e \u00e0 Stockholm, Limula a fait appel \u00e0 plus de 20 experts universitaires et industriels dans le cadre d&rsquo;une s\u00e9rie d&rsquo;ateliers de retour d&rsquo;information \u00e0 Lausanne afin d&rsquo;affiner la conception de LimONE.<\/p>\n\n\n\n<p>\u00ab Le fait de r\u00e9unir des utilisateurs finaux issus du monde universitaire et de l&rsquo;industrie pour ces ateliers a \u00e9t\u00e9 inestimable pour fa\u00e7onner le design de LimONE \u00bb, a expliqu\u00e9 Caroline Boudousqui\u00e9, Head of Solutions chez Limula. \u00ab Cela garantit que LimONE n&rsquo;est pas seulement une innovation technologique, mais une solution pratique et centr\u00e9e sur l&rsquo;utilisateur. \u00bb<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Collaboration avec des leaders de l&rsquo;industrie<\/h4>\n\n\n\n<p>Limula a \u00e9tabli de solides partenariats avec des acteurs cl\u00e9s du secteur des technologies du cancer, notamment des h\u00f4pitaux tels que San Raffaele \u00e0 Milan et l&rsquo;Institut Paoli-Calmettes \u00e0 Marseille, ainsi que des sp\u00e9cialistes du d\u00e9veloppement de processus comme Stemmatters au Portugal et des entreprises de biotechnologie.<\/p>\n\n\n\n<p>Limula a \u00e9tabli des partenariats solides avec des acteurs cl\u00e9s du secteur des th\u00e9rapies cellulaires et g\u00e9niques, notamment des h\u00f4pitaux tels que San Raffaele \u00e0 Milan et l&rsquo;Institut Paoli-Calmettes \u00e0 Marseille, ainsi que des sp\u00e9cialistes du d\u00e9veloppement de processus comme Stemmatters au Portugal et des entreprises de biotechnologie comme Achilles en Angleterre. Ces partenaires apportent des ressources et une expertise aux \u00e9tudes pilotes, garantissant que LimONE r\u00e9pond \u00e0 des normes de performance rigoureuses avant son lancement sur le march\u00e9.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 lausannoise Limula a pr\u00e9sent\u00e9 LimONE, une plateforme de fabrication de th\u00e9rapie cellulaire enti\u00e8rement automatis\u00e9e con\u00e7ue pour rationaliser la production, r\u00e9duire les co\u00fbts et am\u00e9liorer l&rsquo;accessibilit\u00e9 pour les patients, dont les premi\u00e8res unit\u00e9s devraient \u00eatre livr\u00e9es d&rsquo;ici 2028.<\/p>\n","protected":false},"author":6,"featured_media":31728,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1155,1169,1188,1181,1163],"class_list":["post-31731","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-advanced-manufacturing-fr-2","tag-biotech-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-medtech-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Limula d\u00e9voile sa plateforme LimONE | GGBa<\/title>\n<meta name=\"description\" content=\"La soci\u00e9t\u00e9 lausannoise Limula a pr\u00e9sent\u00e9 LimONE, une plateforme de fabrication de th\u00e9rapie cellulaire enti\u00e8rement automatis\u00e9e.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Limula d\u00e9voile sa plateforme LimONE | GGBa\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 lausannoise Limula a pr\u00e9sent\u00e9 LimONE, une plateforme de fabrication de th\u00e9rapie cellulaire enti\u00e8rement automatis\u00e9e.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-10T09:59:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-10T10:01:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Limula d\u00e9voile sa plateforme de fabrication de th\u00e9rapie cellulaire automatis\u00e9e LimONE\",\"datePublished\":\"2025-03-10T09:59:47+00:00\",\"dateModified\":\"2025-03-10T10:01:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/\"},\"wordCount\":494,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg\",\"keywords\":[\"Advanced Manufacturing\",\"Biotech\",\"Healthcare\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/\",\"name\":\"Limula d\u00e9voile sa plateforme LimONE | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg\",\"datePublished\":\"2025-03-10T09:59:47+00:00\",\"dateModified\":\"2025-03-10T10:01:46+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La soci\u00e9t\u00e9 lausannoise Limula a pr\u00e9sent\u00e9 LimONE, une plateforme de fabrication de th\u00e9rapie cellulaire enti\u00e8rement automatis\u00e9e.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"LimONE de Limula int\u00e8gre l'automatisation dans la fabrication de th\u00e9rapie cellulaire, am\u00e9liorant l'\u00e9volutivit\u00e9 et l'accessibilit\u00e9 pour les h\u00f4pitaux et les entreprises de biotechnologie. | \u00a9 Limula\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Limula d\u00e9voile sa plateforme de fabrication de th\u00e9rapie cellulaire automatis\u00e9e LimONE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Limula d\u00e9voile sa plateforme LimONE | GGBa","description":"La soci\u00e9t\u00e9 lausannoise Limula a pr\u00e9sent\u00e9 LimONE, une plateforme de fabrication de th\u00e9rapie cellulaire enti\u00e8rement automatis\u00e9e.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/","og_locale":"fr_FR","og_type":"article","og_title":"Limula d\u00e9voile sa plateforme LimONE | GGBa","og_description":"La soci\u00e9t\u00e9 lausannoise Limula a pr\u00e9sent\u00e9 LimONE, une plateforme de fabrication de th\u00e9rapie cellulaire enti\u00e8rement automatis\u00e9e.","og_url":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-03-10T09:59:47+00:00","article_modified_time":"2025-03-10T10:01:46+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Limula d\u00e9voile sa plateforme de fabrication de th\u00e9rapie cellulaire automatis\u00e9e LimONE","datePublished":"2025-03-10T09:59:47+00:00","dateModified":"2025-03-10T10:01:46+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/"},"wordCount":494,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg","keywords":["Advanced Manufacturing","Biotech","Healthcare","Medical Devices","Medtech"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/","url":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/","name":"Limula d\u00e9voile sa plateforme LimONE | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg","datePublished":"2025-03-10T09:59:47+00:00","dateModified":"2025-03-10T10:01:46+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La soci\u00e9t\u00e9 lausannoise Limula a pr\u00e9sent\u00e9 LimONE, une plateforme de fabrication de th\u00e9rapie cellulaire enti\u00e8rement automatis\u00e9e.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Limula-LimONE-1180x811-1.jpeg","width":1180,"height":811,"caption":"LimONE de Limula int\u00e8gre l'automatisation dans la fabrication de th\u00e9rapie cellulaire, am\u00e9liorant l'\u00e9volutivit\u00e9 et l'accessibilit\u00e9 pour les h\u00f4pitaux et les entreprises de biotechnologie. | \u00a9 Limula"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/limula-devoile-sa-plateforme-de-fabrication-de-therapie-cellulaire-automatisee-limone\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Limula d\u00e9voile sa plateforme de fabrication de th\u00e9rapie cellulaire automatis\u00e9e LimONE"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=31731"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31731\/revisions"}],"predecessor-version":[{"id":31733,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31731\/revisions\/31733"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/31728"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=31731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=31731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=31731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}